Advisors Asset Management, Inc. Repligen Corp Transaction History

Advisors Asset Management, Inc.

  • $5.1 Billion
  • Q1 2024

A detailed history of Advisors Asset Management, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 13,827 shares of RGEN stock, worth $1.67 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
13,827
Previous 11,371 21.6%
Holding current value
$1.67 Million
Previous $2.04 Million 24.41%
% of portfolio
0.05%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$170.78 - $208.42 $419,435 - $511,879
2,456 Added 21.6%
13,827 $2.54 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $97,158 - $157,732
-851 Reduced 6.96%
11,371 $2.04 Million
Q2 2023

Aug 14, 2023
SELL
$138.42 - $180.31 $408,615 - $532,275
-2,952 Reduced 19.45%
12,222 $1.73 Million
Q1 2023

May 12, 2023
SELL
$154.26 - $198.1 $126,647 - $162,640
-821 Reduced 5.13%
15,174 $2.55 Million
Q4 2022

Feb 13, 2023
SELL
$162.42 - $220.56 $690,122 - $937,159
-4,249 Reduced 20.99%
15,995 $2.71 Million
Q3 2022

Nov 08, 2022
SELL
$160.42 - $256.21 $44,115 - $70,457
-275 Reduced 1.34%
20,244 $3.79 Million
Q2 2022

Aug 08, 2022
SELL
$140.68 - $188.02 $296,412 - $396,158
-2,107 Reduced 9.31%
20,519 $3.33 Million
Q1 2022

May 17, 2022
SELL
$161.19 - $257.96 $316,899 - $507,149
-1,966 Reduced 7.99%
22,626 $4.26 Million
Q4 2021

Feb 15, 2022
SELL
$247.59 - $304.47 $239,667 - $294,726
-968 Reduced 3.79%
24,592 $6.51 Million
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $521,788 - $868,558
-2,679 Reduced 9.49%
25,560 $7.39 Million
Q2 2021

Jul 30, 2021
SELL
$165.87 - $220.95 $9,454 - $12,594
-57 Reduced 0.2%
28,239 $5.64 Million
Q1 2021

May 07, 2021
BUY
$180.37 - $226.26 $510,807 - $640,768
2,832 Added 11.12%
28,296 $5.5 Million
Q4 2020

Feb 12, 2021
BUY
$148.08 - $206.57 $417,733 - $582,733
2,821 Added 12.46%
25,464 $4.88 Million
Q3 2020

Nov 16, 2020
BUY
$122.51 - $158.27 $472,031 - $609,814
3,853 Added 20.51%
22,643 $3.34 Million
Q2 2020

Aug 12, 2020
BUY
$94.33 - $140.48 $404,958 - $603,080
4,293 Added 29.61%
18,790 $2.32 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $316,306 - $406,328
3,723 Added 34.56%
14,497 $1.4 Million
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $236,731 - $298,414
3,206 Added 42.36%
10,774 $994,000
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $422,571 - $526,546
5,513 Added 268.27%
7,568 $580,000
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $109,971 - $174,392
2,029 Added 7803.85%
2,055 $177,000
Q3 2017

Nov 07, 2017
BUY
$36.98 - $46.06 $961 - $1,197
26
26 $1,000

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email